CompletedPhase 1NCT00337636
Study of HuCNS-SC Cells in Patients With Infantile or Late Infantile Neuronal Ceroid Lipofuscinosis (NCL)
Studying Neuronal ceroid lipofuscinosis
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- StemCells, Inc.
- Principal Investigator
- Robert Steiner, MDOregon Health and Science University
- Intervention
- Surgery to implant human CNS stem cells (HuCNS-SC)(procedure)
- Enrollment
- 6 enrolled
- Eligibility
- 12 years · All sexes
- Timeline
- 2006 – 2009
Study locations (1)
- Oregon Health and Science University, Portland, Oregon, United States
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT00337636 on ClinicalTrials.govOther trials for Neuronal ceroid lipofuscinosis
Additional recruiting or active studies for the same condition.
- RECRUITINGNCT06844877Italian NCL Registry: a Registry for NCL as an Integration Tool for Future Therapeutic StrategiesIRCCS Fondazione Stella Maris
- RECRUITINGNANCT04613089Natural History and Longitudinal Clinical Assessments in NCL / Batten Disease, the International DEM-CHILD DatabaseUniversitätsklinikum Hamburg-Eppendorf
- ACTIVE NOT RECRUITINGNCT04098211Longitudinal Assessment of Atypical Tripeptidyl Peptidase 1 Enzyme Deficiency PatientsChildren's Hospital of Orange County
- RECRUITINGNANCT03307304Investigations of Juvenile Neuronal Ceroid LipofuscinosisEunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)